Total glucosides of paeony ameliorates chemotherapy-induced neuropathic pain by suppressing microglia pyroptosis through the inhibition of KAT2A-mediated p38 pathway activation and succinylation

Abstract Chemotherapy-induced neuropathic pain (CINP) is a prevalent side effect of chemotherapy. Total glucosides of paeony (TGP) have been shown to be effective in pain management. This study aimed to investigate the efficacy and mechanism of TGP in alleviating CINP. Sprague–Dawley rats were treat...

Full description

Saved in:
Bibliographic Details
Main Authors: Rong Chen, Jiantao Hu, Yang Zhang, Yang Liu, Jingsong Zhu, Zheng Pan, Hua Yang, Qin Wang, Ying Chen, Songjiang Tang, Baojun Min
Format: Article
Language:English
Published: Nature Portfolio 2024-12-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-83207-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559448336728064
author Rong Chen
Jiantao Hu
Yang Zhang
Yang Liu
Jingsong Zhu
Zheng Pan
Hua Yang
Qin Wang
Ying Chen
Songjiang Tang
Baojun Min
author_facet Rong Chen
Jiantao Hu
Yang Zhang
Yang Liu
Jingsong Zhu
Zheng Pan
Hua Yang
Qin Wang
Ying Chen
Songjiang Tang
Baojun Min
author_sort Rong Chen
collection DOAJ
description Abstract Chemotherapy-induced neuropathic pain (CINP) is a prevalent side effect of chemotherapy. Total glucosides of paeony (TGP) have been shown to be effective in pain management. This study aimed to investigate the efficacy and mechanism of TGP in alleviating CINP. Sprague–Dawley rats were treated with oxaliplatin to establish CINP models, and BV2 microglia were exposed to lipopolysaccharides (LPS) to induce pyroptosis. The impact of TGP on CINP was assessed by measuring mechanical withdrawal threshold (MWT), cold pain threshold (CPT), and thermal pain threshold (TPT), as well as inflammatory factor levels. Pyroptosis was evaluated using flow cytometry, lactate dehydrogenase (LDH) release, and pyroptosis marker levels. Quantitative real-time PCR and molecular docking were employed to identify TGP targets, while phospho-kinase arrays, western blotting, and co-immunoprecipitation were used to elucidate the mechanism. Results indicated that TGP increased MWT, CPT, and TPT and inhibited inflammatory factor release in CINP rats. Furthermore, TGP suppressed LPS-induced pyroptosis and downregulated KAT2A expression in BV2 cells; this suppression was reversed by KAT2A overexpression. Mechanistically, KAT2A overexpression activated the p38 pathway and promoted p38 succinylation at K295. KAT2A knockdown inhibited pyroptosis in LPS-induced BV2 cells, an effect that was reversed by the p38 activator metformin. Additionally, the improvements in MWT, CPT, TPT, and inflammatory factor levels observed in CINP rats treated with TGP were negated by KAT2A overexpression. In conclusion, TGP alleviated CINP by suppressing microglial pyroptosis through inhibition of the KAT2A-mediated p38 pathway activation and succinylation. This study provides insights into a potential new therapeutic approach for CINP.
format Article
id doaj-art-8cc0129941984964bbc9b7c3e327446b
institution Kabale University
issn 2045-2322
language English
publishDate 2024-12-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-8cc0129941984964bbc9b7c3e327446b2025-01-05T12:28:23ZengNature PortfolioScientific Reports2045-23222024-12-0114111110.1038/s41598-024-83207-8Total glucosides of paeony ameliorates chemotherapy-induced neuropathic pain by suppressing microglia pyroptosis through the inhibition of KAT2A-mediated p38 pathway activation and succinylationRong Chen0Jiantao Hu1Yang Zhang2Yang Liu3Jingsong Zhu4Zheng Pan5Hua Yang6Qin Wang7Ying Chen8Songjiang Tang9Baojun Min10Department of Pain, The First Affiliated Hospital of Guizhou University of Traditional Chinese MedicineDepartment of Respiratory, Qixingguan District People’s Hospital in Bijie CityDepartment of Anesthesiology, The First Affiliated Hospital of Guizhou University of Traditional Chinese MedicineDepartment of Orthopedics, The First Affiliated Hospital of Guizhou University of Traditional Chinese MedicineDepartment of Pain, The First Affiliated Hospital of Guizhou University of Traditional Chinese MedicineDepartment of Neurosurgery, The First Affiliated Hospital of Guizhou University of Traditional Chinese MedicineDepartment of Neurosurgery, The First Affiliated Hospital of Guizhou University of Traditional Chinese MedicineDepartment of Rheumatology and Hematology, The First Affiliated Hospital of Guizhou University of Traditional Chinese MedicineDepartment of Anesthesiology, The First Affiliated Hospital of Guizhou University of Traditional Chinese MedicineDepartment of Anesthesiology, The First Affiliated Hospital of Guizhou University of Traditional Chinese MedicineDepartment of Anesthesiology, Qianxi People’s HospitalAbstract Chemotherapy-induced neuropathic pain (CINP) is a prevalent side effect of chemotherapy. Total glucosides of paeony (TGP) have been shown to be effective in pain management. This study aimed to investigate the efficacy and mechanism of TGP in alleviating CINP. Sprague–Dawley rats were treated with oxaliplatin to establish CINP models, and BV2 microglia were exposed to lipopolysaccharides (LPS) to induce pyroptosis. The impact of TGP on CINP was assessed by measuring mechanical withdrawal threshold (MWT), cold pain threshold (CPT), and thermal pain threshold (TPT), as well as inflammatory factor levels. Pyroptosis was evaluated using flow cytometry, lactate dehydrogenase (LDH) release, and pyroptosis marker levels. Quantitative real-time PCR and molecular docking were employed to identify TGP targets, while phospho-kinase arrays, western blotting, and co-immunoprecipitation were used to elucidate the mechanism. Results indicated that TGP increased MWT, CPT, and TPT and inhibited inflammatory factor release in CINP rats. Furthermore, TGP suppressed LPS-induced pyroptosis and downregulated KAT2A expression in BV2 cells; this suppression was reversed by KAT2A overexpression. Mechanistically, KAT2A overexpression activated the p38 pathway and promoted p38 succinylation at K295. KAT2A knockdown inhibited pyroptosis in LPS-induced BV2 cells, an effect that was reversed by the p38 activator metformin. Additionally, the improvements in MWT, CPT, TPT, and inflammatory factor levels observed in CINP rats treated with TGP were negated by KAT2A overexpression. In conclusion, TGP alleviated CINP by suppressing microglial pyroptosis through inhibition of the KAT2A-mediated p38 pathway activation and succinylation. This study provides insights into a potential new therapeutic approach for CINP.https://doi.org/10.1038/s41598-024-83207-8Chemotherapy-induced neuropathic painTotal glucosides of paeonyPyroptosisSuccinylationKAT2A
spellingShingle Rong Chen
Jiantao Hu
Yang Zhang
Yang Liu
Jingsong Zhu
Zheng Pan
Hua Yang
Qin Wang
Ying Chen
Songjiang Tang
Baojun Min
Total glucosides of paeony ameliorates chemotherapy-induced neuropathic pain by suppressing microglia pyroptosis through the inhibition of KAT2A-mediated p38 pathway activation and succinylation
Scientific Reports
Chemotherapy-induced neuropathic pain
Total glucosides of paeony
Pyroptosis
Succinylation
KAT2A
title Total glucosides of paeony ameliorates chemotherapy-induced neuropathic pain by suppressing microglia pyroptosis through the inhibition of KAT2A-mediated p38 pathway activation and succinylation
title_full Total glucosides of paeony ameliorates chemotherapy-induced neuropathic pain by suppressing microglia pyroptosis through the inhibition of KAT2A-mediated p38 pathway activation and succinylation
title_fullStr Total glucosides of paeony ameliorates chemotherapy-induced neuropathic pain by suppressing microglia pyroptosis through the inhibition of KAT2A-mediated p38 pathway activation and succinylation
title_full_unstemmed Total glucosides of paeony ameliorates chemotherapy-induced neuropathic pain by suppressing microglia pyroptosis through the inhibition of KAT2A-mediated p38 pathway activation and succinylation
title_short Total glucosides of paeony ameliorates chemotherapy-induced neuropathic pain by suppressing microglia pyroptosis through the inhibition of KAT2A-mediated p38 pathway activation and succinylation
title_sort total glucosides of paeony ameliorates chemotherapy induced neuropathic pain by suppressing microglia pyroptosis through the inhibition of kat2a mediated p38 pathway activation and succinylation
topic Chemotherapy-induced neuropathic pain
Total glucosides of paeony
Pyroptosis
Succinylation
KAT2A
url https://doi.org/10.1038/s41598-024-83207-8
work_keys_str_mv AT rongchen totalglucosidesofpaeonyameliorateschemotherapyinducedneuropathicpainbysuppressingmicrogliapyroptosisthroughtheinhibitionofkat2amediatedp38pathwayactivationandsuccinylation
AT jiantaohu totalglucosidesofpaeonyameliorateschemotherapyinducedneuropathicpainbysuppressingmicrogliapyroptosisthroughtheinhibitionofkat2amediatedp38pathwayactivationandsuccinylation
AT yangzhang totalglucosidesofpaeonyameliorateschemotherapyinducedneuropathicpainbysuppressingmicrogliapyroptosisthroughtheinhibitionofkat2amediatedp38pathwayactivationandsuccinylation
AT yangliu totalglucosidesofpaeonyameliorateschemotherapyinducedneuropathicpainbysuppressingmicrogliapyroptosisthroughtheinhibitionofkat2amediatedp38pathwayactivationandsuccinylation
AT jingsongzhu totalglucosidesofpaeonyameliorateschemotherapyinducedneuropathicpainbysuppressingmicrogliapyroptosisthroughtheinhibitionofkat2amediatedp38pathwayactivationandsuccinylation
AT zhengpan totalglucosidesofpaeonyameliorateschemotherapyinducedneuropathicpainbysuppressingmicrogliapyroptosisthroughtheinhibitionofkat2amediatedp38pathwayactivationandsuccinylation
AT huayang totalglucosidesofpaeonyameliorateschemotherapyinducedneuropathicpainbysuppressingmicrogliapyroptosisthroughtheinhibitionofkat2amediatedp38pathwayactivationandsuccinylation
AT qinwang totalglucosidesofpaeonyameliorateschemotherapyinducedneuropathicpainbysuppressingmicrogliapyroptosisthroughtheinhibitionofkat2amediatedp38pathwayactivationandsuccinylation
AT yingchen totalglucosidesofpaeonyameliorateschemotherapyinducedneuropathicpainbysuppressingmicrogliapyroptosisthroughtheinhibitionofkat2amediatedp38pathwayactivationandsuccinylation
AT songjiangtang totalglucosidesofpaeonyameliorateschemotherapyinducedneuropathicpainbysuppressingmicrogliapyroptosisthroughtheinhibitionofkat2amediatedp38pathwayactivationandsuccinylation
AT baojunmin totalglucosidesofpaeonyameliorateschemotherapyinducedneuropathicpainbysuppressingmicrogliapyroptosisthroughtheinhibitionofkat2amediatedp38pathwayactivationandsuccinylation